LEONARDO DRS ($DRS) posted quarterly earnings results on Wednesday, July 30th. The company reported earnings of $0.23 per share, beating estimates of $0.22 by $0.01. The company also reported revenue of $829,000,000, missing estimates of $835,728,832 by $-6,728,832.
You can see Quiver Quantitative's $DRS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LEONARDO DRS Insider Trading Activity
LEONARDO DRS insiders have traded $DRS stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $DRS stock by insiders over the last 6 months:
- WILLIAM III LYNN (Chief Executive Officer) has made 0 purchases and 2 sales selling 90,000 shares for an estimated $3,057,750.
- MICHAEL DIPPOLD (EVP and CFO) sold 26,618 shares for an estimated $870,408
- MARK DORFMAN (EVP, GC and Secretary) sold 20,034 shares for an estimated $654,911
- PAMELA MORROW (SVP and Controller) has made 0 purchases and 2 sales selling 11,004 shares for an estimated $359,178.
- JOHN BAYLOUNY (EVP and COO) has made 0 purchases and 3 sales selling 10,587 shares for an estimated $343,442.
- SALLY WALLACE (EVP, Business Operations) has made 0 purchases and 2 sales selling 9,851 shares for an estimated $321,978.
- DAVID W CAREY sold 6,438 shares for an estimated $295,761
- ERIC SALZMAN has made 0 purchases and 2 sales selling 6,954 shares for an estimated $236,853.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LEONARDO DRS Hedge Fund Activity
We have seen 136 institutional investors add shares of LEONARDO DRS stock to their portfolio, and 125 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SILVERCREST ASSET MANAGEMENT GROUP LLC removed 1,223,529 shares (-97.7%) from their portfolio in Q1 2025, for an estimated $40,229,633
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 1,100,547 shares (-57.3%) from their portfolio in Q1 2025, for an estimated $36,185,985
- VAN ECK ASSOCIATES CORP added 808,798 shares (+109.8%) to their portfolio in Q1 2025, for an estimated $26,593,278
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 804,938 shares (+16.0%) to their portfolio in Q1 2025, for an estimated $26,466,361
- TEACHER RETIREMENT SYSTEM OF TEXAS removed 777,233 shares (-72.8%) from their portfolio in Q1 2025, for an estimated $25,555,421
- BLACKROCK, INC. added 437,056 shares (+6.6%) to their portfolio in Q1 2025, for an estimated $14,370,401
- LORD, ABBETT & CO. LLC added 429,922 shares (+116.3%) to their portfolio in Q1 2025, for an estimated $14,135,835
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LEONARDO DRS Analyst Ratings
Wall Street analysts have issued reports on $DRS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 07/11/2025
- Goldman Sachs issued a "Buy" rating on 06/30/2025
- B of A Securities issued a "Buy" rating on 03/07/2025
To track analyst ratings and price targets for LEONARDO DRS, check out Quiver Quantitative's $DRS forecast page.
LEONARDO DRS Price Targets
Multiple analysts have issued price targets for $DRS recently. We have seen 5 analysts offer price targets for $DRS in the last 6 months, with a median target of $48.0.
Here are some recent targets:
- Michael Ciarmoli from Truist Securities set a target price of $51.0 on 07/11/2025
- Anthony Valentini from Goldman Sachs set a target price of $49.0 on 06/30/2025
- Seth Seifman from JP Morgan set a target price of $48.0 on 06/16/2025
- Kristine Liwag from Morgan Stanley set a target price of $44.0 on 05/06/2025
- Ronald Epstein from B of A Securities set a target price of $40.0 on 03/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
